Hikurangi Bioactives Limited Partnership (HBLP) is a joint venture between Hikurangi Enterprises Limited (HEL), New Zealand Nutraceuticals Limited (NZNL) and Hikurangi Bioactives General Partner Limited.
When HBLP dividends are paid, 60% goes to HEL and 40% to NZNL.
HBLP has invested in a range of biotechnology projects with research organisations in New Zealand and overseas. A number of joint projects have been established between HBLP, private companies and research entities. In some of the arrangements HBLP owns all of the Intellectual Property developed, in other projects it owns a share of the IP and in others (ie. most of the kānuka and kina projects), HBLP owns no IP but works closely with the IP owners.
HBLP has two directors: Carey Manuel and Damian Skinner.
– – –
HBLP has developed a new resource about kānuka, based on a two-year research project funded by the Ministry for Primary Industries. This is available for download here.